About IMRB
The Mondor Institute for Biomedical Research (IMRB, U955 Inserm – Université Paris Est Créteil, UPEC) is one of the main biomedical research centres in the eastern part of the Paris region with national and international influence. The research teams develop high-level translational research in a wide variety of fields in direct connection with healthcare services […]
Read more about the IMRB
News
IMI2 CARE Project: VRI-Inserm, coordinator of the European Public-Private Consortium, created to accelerate the development of Covid-19 treatments
The largest European initiative to accelerate the development of therapies for COVID-19 and future coronavirus threats was launched in Brussels on August 18. CARE (Corona Accelerated R&D in Europe) is a €77.7 million European public-private consortium of the Innovative Medicines Initiative (IMI) created to accelerate the development of therapies for Covid-19 and coronaviruses. Professor […]
Read moreSee all the news
Incoming seminars
Thesis defence: Anti-erythrocyte alloimmunization and variants of the HR system: new bioinformatics approaches :
«Aline Floc'h - 2pm - Videoconference»
When environmental sciences meet health sciences: 2nd OSU-IMRB seminar (videoconference) :
«From 11am to 2pm - Videoconference»
Régulation de la différenciation érythroide terminale – applications physiopathologiques :
«Geneviève Courtois - 12h – Amphi 1 (provided)»
All incoming seminars
Departments
